- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Central Core Disease
Total 429114 results
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomRecruiting
-
St. Jude Children's Research HospitalRecruiting
-
Melanoma Institute AustraliaNovartisRecruiting
-
The First People's Hospital of ChangzhouNot yet recruiting
-
University of LouisvilleJames Graham Brown Cancer CenterRecruiting
-
National Cancer Institute (NCI)SuspendedMalignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Refractory CholangiocarcinomaUnited States
-
National Cancer Institute (NCI)Indiana University School of MedicineActive, not recruitingThymoma | Thymus NeoplasmsUnited States
-
Centre Hospitalier Universitaire de la RéunionCompleted
-
Chung Shan Medical UniversityEnrolling by invitationLung Nodules, Early Lung Cancer, Artificial Intelligence, Chest CT, Minimally Invasive Surgery, Lung Image Analysis SoftwareTaiwan
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
University of Illinois at ChicagoWithdrawnKidney Transplant Rejection | Positive FCXM (T or B Cell Positive) | Positive CDC Cross-Match (B Cell Positive) | Kidney/Pancreas Transplant RejectionUnited States
-
Novartis PharmaceuticalsAvailable
-
AbbVieActive, not recruitingCancer | Acute Myeloid Leukemia (AML)United States, Australia, Brazil, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Spain, Switzerland, Taiwan, United Kingdom
-
Memorial Sloan Kettering Cancer CenterXcovery Holding Company, LLCActive, not recruiting
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Italy, United Kingdom, Netherlands, Canada, Germany, Australia, Spain, Switzerland, France
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalActive, not recruiting
-
UNC Lineberger Comprehensive Cancer CenterSyndax PharmaceuticalsCompletedMelanomaUnited States
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
Provectus Biopharmaceuticals, Inc.Active, not recruiting
-
University of LouisvilleJames Graham Brown Cancer CenterWithdrawn
-
Centre Hospitalier Universitaire de NiceCompleted
-
Craig L Slingluff, JrCancer Research Institute, New York City; Ludwig Institute for Cancer ResearchTerminated
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, United States, Germany, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Finland, France, Greece, Israel, Mexico, New Zealand, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom
-
The Christie NHS Foundation TrustBristol-Myers Squibb; University of Manchester; Manchester Academic Health Science...Active, not recruiting
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Completed
-
Nottingham University Hospitals NHS TrustNewcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...TerminatedCancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological MalignancyUnited Kingdom
-
Institut Claudius RegaudCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
Shanghai Kechow Pharma, Inc.Completed
-
Rockefeller UniversityOregon Health and Science University; University of California, Irvine; Skin...CompletedMelanomaUnited States
-
Rennes University HospitalQIAGEN Gaithersburg, IncCompleted
-
OncoSec Medical IncorporatedCompleted
-
PfizerPierre Fabre LaboratoriesTerminated
-
Vitaccess LtdRoyal Marsden NHS Foundation Trust; Melanoma UKCompleted
-
Centre Hospitalier Universitaire de BesanconCentre Georges Francois LeclercActive, not recruiting
-
TakedaCompletedCarcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid TumorsSpain, Italy, Netherlands, France
-
Hebei Yanda Ludaopei HospitalCompletedRelapsed/Refractory Acute Myeloid LeukemiaChina
-
Regeneron PharmaceuticalsCompletedMelanomaUnited States
-
Bristol-Myers SquibbCompleted
-
Ludwig Institute for Cancer ResearchBristol-Myers Squibb; Conquer Cancer FoundationCompleted
-
EuMelaReg gGmbHActive, not recruiting
-
University of MiamiCompleted
-
IpsenTerminatedNeuroendocrine Tumors in LungCanada, United States, Germany, France, United Kingdom, Netherlands, Spain, Denmark, Italy, Austria, Poland
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); Janssen...TerminatedAcute Myeloid Leukemia | Acute Myeloid Leukemia, Relapsed, AdultUnited States
-
Bristol-Myers SquibbActive, not recruiting
-
Selcuk UniversityCompletedMusic | Preterm | Vital Signs | Nutrition Disorder, InfantTurkey
-
Bristol-Myers SquibbActive, not recruiting
-
The First Affiliated Hospital of Soochow UniversityJining Medical UniversityCompletedAcute Myeloid Leukemia, Relapsed, AdultChina